This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Cramer: Get Your Portfolio Into the Bunker

I have three others that Peltier and I agree on that are worth buying in the event of a debt default or the plummeting I expect ahead of such an event -- one that is being described as impossible by both sides, and is often talked about as if it's as unlikely as a meteor hitting the Capitol building.

The first is Pfizer ( PFE). This is about as plain-vanilla a drug company as you can get. Normally I would select Bristol-Myers ( BMY), but that stock is up on a spike. I might have gone with Eli Lilly ( LLY), but I didn't like what I heard about the pipeline at last week's analyst meeting. Merck's ( MRK) got yield and a share buyback, but it does not have the pipeline that many want. That's why Pfizer would seem to be such a natural. Pfizer continues to churn out earnings, and it remains committed to raising its dividend. The company is also so proactive that it actually split off its Zoetis ( ZTS) animal-health division in order to bring out value. I like that.

Second is Campbell Soup ( CPB). Here's a company that simply won't go away. It is a serial dividend-raiser, and I think that the company lives in constant fear of takeover bid, as its business looks a lot like the business of Heinz, which got a takeover bid earlier this year from none other than a team that included Berkshire Hathaway ( BRK.A/ BRK.B). There's nothing more consistent than soups and snacks.

Finally, the last Peltier-blessed stock: Altria ( MO). Look, I know that there's tremendous controversy and resistance involved in buying tobacco stocks, but this is a company that keeps taking share and keeps raising its dividend every August. Talk about a constant! The company behind Marlboro is a clockwork dividend-raiser.

Pfizer, Campbells and Altira: Two 3-percenters and a 5-percenter, all with growth prospects. Terrific Washington antidotes.

You know what else will get clocked? The telco stocks. The Dividend Stock Advisor likes AT&T ( T), but I could see some earnings risk coming down the pike from a recession. I want a company that has a terrific wireless business, because wireless growth continues unabated. I want Verizon ( VZ), which just purchased the rest of Verizon Wireless that it doesn't own from Vodafone ( VOD).

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Our Tweets

Partners Compare Online Brokers

Top Rated Stocks Top Rated Funds Top Rated ETFs